Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested

Comments
Loading...

On Wednesday, May 18, Clearmind Medicine Inc. CMNDF will meet with the Center for Drug Evaluation and Research (CDER), a department within the FDA.

The objective of the meeting is to discuss Clearmind’s proposed first-in-human study evaluating its proprietary drug candidate CMND-100, developed for the treatment of alcohol use disorder. Clearmind could later submit an investigational new drug application.

CMND-100, the company’s flagship compound, reportedly produces a reduction in the desire of consuming alcohol. According to the company, the substance could innervate “neural pathways such as 5-HT1A that lead to ‘sensible behavior.’”

Dr. Adi Zuloff-Shani, Clearmind’s CEO commented: “We recently submitted questions to the FDA as part of our pre-IND submission package. With answers to these questions and any additional information provided by the FDA during the meeting, we will be in position to address any open issues or requests of the FDA before submitting our IND.”

Pre-clinical data for the compound is promisingAnother study, done in collaboration with SciSparc Ltd. SPRC, showed that combining CMND-100 with SciSparc's CannAmide could also be beneficial when treating alcoholism.

Photo: Courtesy of DiamondRehab Thailand on Unsplash

SPRC Logo
SPRCSciSparc Ltd
$0.27902.91%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
24.31
Growth
-
Quality
-
Value
79.60
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!